Is the common skin bacterium Corynebacterium striatum evolving into a dangerous clinical threat?

Is the common skin bacterium Corynebacterium striatum evolving into a dangerous clinical threat?
Image: Intellect (generated)

In short: Usually a harmless resident of human skin, Corynebacterium striatum is increasingly identified as an emerging pathogen. While often commensal, this rod-shaped bacterium can cause severe, invasive infections in both immunocompromised and healthy hosts, challenging medical professionals with its growing resistance to many standard antibiotics and potential for hospital-based outbreaks.

Corynebacterium striatum belongs to a genus of gram-positive, aerobic, and facultative anaerobic bacilli. Named for their club-like appearance, these bacteria are typically found in the human microbiota. While the genus is widely known for including C. diphtheriae, the causative agent of diphtheria, many other species are non-pathogenic. However, C. striatum has gained attention as an opportunistic pathogen capable of exploiting weakened host defenses or surgical wounds to cause systemic illness.

The clinical profile of C. striatum is shifting. Once considered a benign skin commensal, it is now frequently isolated from blood, body fluids, and tissues in patients with serious infections. Research indicates that risk factors include prolonged hospitalization, the use of invasive medical procedures, and long-term treatment with broad-spectrum antibiotics. Alarmingly, there is mounting evidence that it can infect immunocompetent individuals and spread between patients in intensive care units, leading to significant nosocomial outbreaks.

Treating these infections is complicated by the bacterium's resistance profile. A systematic review of 85 cases found that while some strains remain susceptible to vancomycin, linezolid, and teicoplanin, others show high resistance to common drugs like fluoroquinolones, aminoglycosides, and various beta-lactams. Despite treatment, fatal outcomes have been reported in nearly 20% of studied cases. Because of this, experts advocate for advanced diagnostic methods, such as gene sequencing or mass spectrometry, to ensure accurate identification and appropriate therapy.

The rise of C. striatum highlights the complex, evolving relationship between human microbiota and clinical medicine. As the bacterium adapts to hospital environments and antibiotic pressures, it is increasingly viewed as an emerging pathogen. Establishing evidence-based treatment guidelines is now a priority for clinicians, as the pathogen's ability to cause serious, sometimes fatal, invasive infections in diverse patient populations continues to challenge current medical practices.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/gardening-corynebacterium.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…